Fundely
3137
Axel Mark
3624
Twenty-four seven
7074
Visumo
303A
Nomura Micro Science
6254
(FY)Aug 31, 2024 | (Q4)Aug 31, 2024 | (Q3)May 31, 2024 | (Q2)Feb 29, 2024 | (Q1)Nov 30, 2023 | (FY)Aug 31, 2023 | (Q4)Aug 31, 2023 | (Q3)May 31, 2023 | (Q2)Feb 28, 2023 | (Q1)Nov 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | 11.19%50.59B | 6.37%12.83B | 3.59%12.74B | 18.31%13.11B | 18.44%11.9B | 27.08%45.5B | 25.53%12.06B | 28.34%12.3B | 21.63%11.08B | 34.12%10.05B |
Cost of revenue | 14.35%30.94B | 7.91%7.95B | 3.19%7.66B | 24.81%7.99B | 25.16%7.33B | 34.68%27.05B | 36.68%7.37B | 41.34%7.42B | 27.08%6.4B | 32.98%5.86B |
Gross profit | 6.56%19.65B | 3.94%4.88B | 4.18%5.08B | 9.42%5.13B | 9.05%4.57B | 17.38%18.44B | 11.24%4.69B | 12.60%4.88B | 14.89%4.68B | 35.75%4.19B |
Operating expense | -1.34%18.64B | 1.84%4.77B | 2.88%4.64B | -2.68%4.75B | -7.05%4.47B | -10.42%18.9B | -11.20%4.69B | -14.53%4.51B | -11.36%4.89B | -4.28%4.81B |
Staff costs | 1.37%9.73B | ---- | ---- | ---- | ---- | -10.06%9.6B | ---- | ---- | ---- | ---- |
Selling and administrative expenses | -12.42%1.43B | ---- | ---- | ---- | ---- | 5.14%1.64B | ---- | ---- | ---- | ---- |
-Selling and marketing expense | 32.98%254M | ---- | ---- | ---- | ---- | 29.93%191M | ---- | ---- | ---- | ---- |
-General and administrative expense | -18.42%1.18B | ---- | ---- | ---- | ---- | 2.56%1.44B | ---- | ---- | ---- | ---- |
Depreciation and amortization | -5.76%835M | ---- | ---- | ---- | ---- | -17.04%886M | ---- | ---- | ---- | ---- |
-Depreciation | -5.76%835M | ---- | ---- | ---- | ---- | -17.04%886M | ---- | ---- | ---- | ---- |
Rent and land expenses | -6.24%2.87B | ---- | ---- | ---- | ---- | -19.95%3.06B | ---- | ---- | ---- | ---- |
Other operating expenses | 1.59%3.77B | ---- | ---- | ---- | ---- | -6.55%3.71B | ---- | ---- | ---- | ---- |
Operating profit | 322.96%1.01B | 1,980.00%104M | 20.22%440M | 284.58%371M | 115.25%95M | 91.58%-453M | 100.47%5M | 138.65%366M | 85.98%-201M | 67.90%-623M |
Net non-operating interest income (expenses) | -1.32%-77M | -21.05%-23M | -15.79%-22M | 15.79%-16M | 15.79%-16M | 7.32%-76M | 9.52%-19M | 13.64%-19M | 9.52%-19M | -5.56%-19M |
Non-operating interest income | 200.00%21M | 50.00%6M | 66.67%5M | --5M | --5M | --7M | --4M | --3M | --0 | --0 |
Non-operating interest expense | 18.07%98M | 26.09%29M | 22.73%27M | 10.53%21M | 10.53%21M | 1.22%83M | 9.52%23M | 0.00%22M | -9.52%19M | 5.56%19M |
Net investment income | -77.78%8M | -81.25%6M | 0.00%1M | 0 | 0.00%1M | -38.98%36M | -44.83%32M | 1M | 2M | 1M |
Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
Gain(Loss) on derecognition of available-for-sale financial assets | 1,858.33%235M | 0 | 11M | -2M | 5,550.00%226M | -86.21%12M | -63.64%8M | 0 | 0 | 4M |
Income from associates and other participating interests | ||||||||||
Special income (charges) | 127.34%149M | 37.50%-60M | 86.61%-15M | 228.92%214M | 105.85%10M | -114.60%-545M | -242.86%-96M | -112.32%-112M | -690.48%-166M | -105.95%-171M |
Less:Restructuring and mergern&acquisition | --0 | --0 | -125.00%-1M | 125.00%1M | --0 | --0 | 50.00%-8M | -69.23%4M | ---4M | --8M |
Less:Impairment of capital assets | 0.00%2M | ---- | ---- | ---- | ---- | -50.00%2M | ---- | ---- | ---- | ---- |
Less:Other special charges | -821.43%-202M | 193.02%40M | -40.00%15M | -1,213.64%-245M | -150.00%-12M | 100.67%28M | 59.43%-43M | 102.10%25M | 540.00%22M | 100.83%24M |
Less:Write off | -90.10%51M | -87.59%18M | -98.80%1M | -79.73%30M | -98.56%2M | 14.19%515M | -0.68%145M | -69.14%83M | 572.73%148M | 892.86%139M |
Other non-operating income (expenses) | 6.94%-67M | -15.38%-60M | -1,200.00%-26M | 188.89%8M | 222.22%11M | -107.94%-72M | 48.51%-52M | -100.75%-2M | 84.48%-9M | -101.13%-9M |
Income before tax | 212.84%1.25B | 66.67%-44M | 67.09%391M | 247.06%575M | 139.90%326M | -62.17%-1.11B | 88.38%-132M | 3.54%234M | 73.69%-391M | -147.67%-817M |
Income tax | 74.78%-85M | 47.98%-232M | 120.00%99M | -350.00%-30M | 50.00%78M | -487.36%-337M | -2,127.27%-446M | 4.65%45M | 700.00%12M | 116.67%52M |
Net income | 273.47%1.33B | -39.68%190M | 54.50%292M | 249.75%605M | 128.42%247M | 0.13%-769M | 127.18%315M | 2.72%189M | 72.79%-404M | -151.42%-869M |
Net income continuous operations | 273.34%1.33B | -40.13%188M | 54.50%292M | 250.12%605M | 128.54%248M | 0.00%-769M | 127.12%314M | 3.28%189M | 72.84%-403M | -151.42%-869M |
Noncontrolling interests | 0 | 0 | 0 | 0 | ||||||
Net income attributable to the company | 273.34%1.33B | -40.00%189M | 54.50%292M | 249.75%605M | 128.42%247M | 0.13%-769M | 127.16%315M | 2.72%189M | 72.78%-404M | -151.42%-869M |
Preferred stock dividends | ||||||||||
Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Net income attributable to common stockholders | 273.34%1.33B | -40.00%189M | 54.50%292M | 249.75%605M | 128.42%247M | 0.13%-769M | 127.16%315M | 2.72%189M | 72.78%-404M | -151.42%-869M |
Gross dividend payment | ||||||||||
Basic earnings per share | 273.40%63.55 | -39.84%9.03 | 53.54%13.88 | 249.74%28.84 | 128.47%11.8 | 0.14%-36.65 | 127.14%15.01 | 2.96%9.04 | 72.78%-19.26 | -151.43%-41.44 |
Diluted earnings per share | 273.40%63.55 | -40.00%9.0064 | 54.11%13.88 | 249.69%28.83 | 128.47%11.8 | 0.14%-36.65 | 127.14%15.01 | 2.72%9.0064 | 72.78%-19.26 | -151.43%-41.44 |
Dividend per share | 133.33%14 | 33.33%8 | 0 | 6 | 0 | 0.00%6 | 6 | 0 | 0 | 0 |
Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |